Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
TRMT2A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
PHF20 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IDH3G - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CSRP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NVL - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RALGDS - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TMEM165 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DDX31 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
USP21 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SSBP4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RUFY3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
STX6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DCAF8 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CHEK2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ELAC2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DCUN1D4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SYNRG - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
L3MBTL2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KIZ - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on